RA Pharmacology Flashcards
MOA: Prednisone
Acts on NF-kß and AP-1 to cause immunosuppression Activates Lipocortin which inhibits PLA2
MOA: Methotrexate
Blocks Thymidylate Synthase –> accumulation of AICAR –> adenosine efflux –> adenosine activating GPCR –> anti-inflammatory effects
MOA: Hydroxychloroquine
Weak base that increases pH in lysosomes preventing peptide loading onto MHC2
MOA: Leflunomide
Blocks synthesis of ribonucleotides inhibiting T cell proliferation
MOA: Etanercept
TNF inhibitor
MOA: Infliximab
TNF inhibitor
MOA: Adalimumab
TNF inhibitor
MOA: Rituximab
Binds CD20 on B cells acting as opsonizing agent –> depletion of immature B cells –> decreased production of autoAb
MOA: Abatacept
Prevents CD28 binding w/ CD80/86 preventing activation of T cells by APCs
MOA: Tocilizumab
Anti-IL-6R IgG Ab limiting hepatic acute phase response
MOA: Tofacitinib
JAK3 enzyme inhibitor
MOA: Anakinra
Blocks pro-inflammatory activity of IL-1
Clinical application: Prednisone
Relieve pain/inflammation until DMARD kicks in Tx for flare ups
Clinical application: Methotrexate
1st choice for RA
Clinical application: Hydroxychloroquine
Combined w/ MTX (safe in pregnancy)